Evaluation of New Risk-based Regulatory Approach to Classification of GMP Deficiencies (Review)
Introduction. This paper is devoted to analysis of a new risk-based regulatory approach to the classification of deficiencies found by inspections of medicines manufacturers, which is undoubtedly relevant.Text. The article describes the new definitions for the deficiencies found in the medicinal pro...
Main Authors: | V. N. Shestakov, Yu. V. Podpruzhnikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2020-08-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/830 |
Similar Items
-
RISK ANALYSIS OF THE DEFICIENCIES FOUND BY THE GMP INSPECTIONS
by: Yu. V. Podpruznikov, et al.
Published: (2019-01-01) -
TOPICAL ISSUES OF TRAINING OF GMP INSPECTORS
by: V. N. Shestakov, et al.
Published: (2019-01-01) -
Assessing the Correlation Between GMP Deviations and Potential Quality Defects of Medicinal Products: the Result of the Survey of Qualified Persons
by: V. A. Orlov, et al.
Published: (2020-05-01) -
REVIEW, CHARACTERISTICS AND ANALYSIS OF THE LAST CHANGES IN THE GMP REQUIREMENTS
by: Yu. V. Podpruznikov, et al.
Published: (2019-01-01) -
Responsibilities of the Marketing Authorisation Holders in Respect of GMP Compliance (Review)
by: A. P. Meshkovskiy, et al.
Published: (2020-11-01)